Shahroz Kidwai, MD
Emergency Medicine · Corsicana, TXNPI 1013200062
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 20 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by Novo Nordisk at 43.6% of the total.
Across 20 payments — averaging $13.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$119
- Pfizer$73
- Radius Health, Inc.$27
- Shire North American Group Inc$18
- Boehringer Ingelheim$13
- Merck$12
- plus $12 from 1 others
What the payments were for
- Food & beverage$274100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 9 | $119 |
| Pfizer | 5 | $73 |
| Radius Health, Inc. | 2 | $27 |
| Shire North American Group Inc | 1 | $18 |
| Boehringer Ingelheim | 1 | $13 |
| Merck | 1 | $12 |
| Johnson & Johnson | 1 | $12 |
How this compares
$274 in reported general payments places this provider in the 80th percentile of 3,952 emergency medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Hyclate | 17 | $169 |
| Ondansetron OdtOndansetron | 13 | $118 |
| Methylprednisolone | 14 | $109 |
| Ciprofloxacin Hcl | 20 | $99 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 21 | $78 |
| Cephalexin | 14 | $63 |
Paid to pharmacies, not to this prescriber.
Other emergency medicine in Corsicana
- John McKinneyTyler$1.9M
- William PeacockHouston$513K
- Myiesha TaylorSunnyvale$369K
- James WilliamsSan Antonio$360K
- Armando MolinaEl Paso$290K
- Arthur AbelloAustin$204K
- Farid DharamsiDallas$159K
- David RobinsonHouston$143K
- Basil KhalafHouston$93K
- Elizabeth FaganMcKinney$67K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.